Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer: 10-year follow-up

Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each year. For many patients, radiotherapy is a standard treatment option that offers outcomes comparable to surgery, particularly for localized disease. As an outpatient procedure, it allows men to maintain much of their daily routine during treatment. However, traditional radiotherapy schedules typically span several weeks, which can be burdensome for patients and put pressure on health care structures and radiotherapy capacity. A major clinical trial (HYPO-RT-PC) has shown that a significantly shorter course of radiotherapy for localized prostate cancer is just...